Economic Analyses

EHE SAS has performed studies in a large number of disease areas

• Rheumatology
  • Rheumatoid arthritis (RA)
  • Ankylosing spondylitis (AS)
• Neurology
  • Multiple sclerosis (MS)
• Ophthalmology
  • Glaucoma
  • Cataract
  • Macular edema
• Urology
• • Urge incontinence/overactive bladder
  • Stress urinary incontinence (SUI)
  • Benign prostatic hyperplasia (BPH)
  • Vesicoureteral reflux (VUR)
• Gynaecology
  • Menorrhagia
• Cardiology
  • Severe heart failure (CHD)
• Oncology
  • Breast cancer
  • Non small cell lung cancer (NSCL)
  • Non-Hodgkins Lymphoma (NHL)
  • Chronic Lymphocytic Leukaemia (CLL)

These studies have been performed in different European countries as well as North America.

EHE SAS works with an informal network of top specialists from academia and consulting in each country to provide high quality work to sponsors.

Training Programs

EHE SAS also offers tailor-made education programs (1 – 12 days) in health economics and economic evaluation. Two types of courses are offered:

-         A general overview of concepts and methods for a broad audience

-         Courses built around a specific disease where all concepts and methods are made explicit using examples from this disease for medical professionals

Through the EUROPEAN SCHOOL OF HEALTH ECONOMICS, EHE SAS offers one of Europe’s most complete education programs in Health Economics of Pharmaceuticals and other Medical Interventions. This annual program lasts three times one week and takes place in spring.

Top